BiotechTube

JR-171

Phase 1/2Completed
0 watching 0 views this week⚡ Active
40
Hype Score

Development Stage

✓
Pre-clinical
2
Phase 1
3
Phase 2
4
Phase 3
5
Approved
Indication / Disease

Mucopolysaccharidosis I

Conditions

Mucopolysaccharidosis I

Trial Timeline

Oct 28, 2021 → May 2, 2025

NCT ID
NCT04453085

About JR-171

JR-171 is a phase 1/2 stage product being developed by JCR Pharmaceuticals for Mucopolysaccharidosis I. The current trial status is completed. This product is registered under clinical trial identifier NCT04453085. Target conditions include Mucopolysaccharidosis I.

Hype Score Breakdown

Clinical
13
Activity
8
Company
9
Novelty
4
Community
3

Clinical Trials (1)

NCT IDPhaseStatus
NCT04453085Phase 1/2Completed

Competing Products

20 competing products in Mucopolysaccharidosis I

See all competitors
ProductCompanyStageHype Score
OdiparcilInventivaPhase 2
47
anakinraSwedish Orphan BiovitrumPhase 1/2
40
laronidaseSanofiApproved
84
LaronidaseSanofiApproved
84
Aldurazyme (Recombinant Human Alpha-L-Iduronidase) + Aldurazyme (Recombinant Human Alpha-L-Iduronidase)SanofiPhase 2
51
Aldurazyme (Recombinant Human Alpha-L-Iduronidase) + Aldurazyme (Recombinant Human Alpha-L-Iduronidase) + Aldurazyme (Recombinant Human Alpha-L-Iduronidase) + Aldurazyme (Recombinant Human Alpha-L-Iduronidase)SanofiApproved
84
Laronidase + Cyclosporine A (CsA) + Azathioprine (Aza)SanofiPhase 1/2
40
Aldurazyme (Recombinant Human Alpha-L-Iduronidase)SanofiPhase 3
76
rhIDU (recombinant human-Alpha-L-Iduronidase) + PlaceboSanofiPhase 3
76
Aldurazyme + Aldurazyme + placeboSanofiPhase 3
76
LaronidaseSanofiApproved
84
JR-141JCR PharmaceuticalsPhase 2/3
64
JR-441 + JR-441 + JR-441JCR PharmaceuticalsPhase 1/2
40
JR-446JCR PharmaceuticalsPhase 1/2
40
JR-141JCR PharmaceuticalsPhase 2
51
JR-141 + Idursulfase + JR-141 or IdursulfaseJCR PharmaceuticalsPhase 3
76
JR-141JCR PharmaceuticalsPhase 3
76
JR-171 (lepunafusp alfa)JCR PharmaceuticalsPhase 1/2
40
JR-141JCR PharmaceuticalsPhase 1/2
40
JR-141JCR PharmaceuticalsPhase 2/3
64

Other Products from JCR Pharmaceuticals

JR-141 + Idursulfase + JR-141 or IdursulfasePhase 3
76
JR-141Phase 3
76
JR-141Phase 2/3
64
JR-141Phase 2/3
64
JR-141Phase 2
51